English
简体中文
Total: £ 56.28
Published Date: 2025-04-01 | Pages: 78 | Tables: 78 | Medical Care
The global market for Multi-Target CAR-T Cell Therapy was valued at US$ 1437 million in the year 2024 and is projected to reach a revised size of US$ 2015 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Multi-target CAR-T cell therapy is an innovative cellular immunotherapy method that utilizes genetic engineering to introduce chimeric antigen receptors (CARs) capable of recognizing multiple tumor antigens into T cells, thereby endowing T cells with the ability to attack multiple tumor cells simultaneously. Compared with single-target CAR-T cell therapy, this therapy has stronger antitumor effects and lower antigen escape risks. Multi-target CAR-T cell therapy has shown great potential in treating various types of cancers, particularly in providing more comprehensive and durable treatment effects against tumors with complex antigen expression profiles.
North American market for Multi-Target CAR-T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Multi-Target CAR-T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Multi-Target CAR-T Cell Therapy in Hematologic Malignancies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Multi-Target CAR-T Cell Therapy include Persongen, Juventas, Gracell, Precision-Biotech, Carsgen, Novatim, Bioheng, Iasobio, BMS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Multi-Target CAR-T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-Target CAR-T Cell Therapy.
The Multi-Target CAR-T Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multi-Target CAR-T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi-Target CAR-T Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Persongen
Juventas
Gracell
Precision-Biotech
Carsgen
Novatim
Bioheng
Iasobio
BMS
Segment by Type
Targeting CD19 and CD22
Targeting BCMA and CD19
Others
Segment by Application
Hematologic Malignancies
Solid Tumors
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi-Target CAR-T Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi-Target CAR-T Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Targeting CD19 and CD22
1.2.3 Targeting BCMA and CD19
1.2.4 Others
1.3 Market by Application
1.3.1 Global Multi-Target CAR-T Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hematologic Malignancies
1.3.3 Solid Tumors
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multi-Target CAR-T Cell Therapy Market Perspective (2020-2031)
2.2 Global Multi-Target CAR-T Cell Therapy Growth Trends by Region
2.2.1 Global Multi-Target CAR-T Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Multi-Target CAR-T Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Multi-Target CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Multi-Target CAR-T Cell Therapy Market Dynamics
2.3.1 Multi-Target CAR-T Cell Therapy Industry Trends
2.3.2 Multi-Target CAR-T Cell Therapy Market Drivers
2.3.3 Multi-Target CAR-T Cell Therapy Market Challenges
2.3.4 Multi-Target CAR-T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multi-Target CAR-T Cell Therapy Players by Revenue
3.1.1 Global Top Multi-Target CAR-T Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Multi-Target CAR-T Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Multi-Target CAR-T Cell Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Multi-Target CAR-T Cell Therapy Revenue
3.4 Global Multi-Target CAR-T Cell Therapy Market Concentration Ratio
3.4.1 Global Multi-Target CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi-Target CAR-T Cell Therapy Revenue in 2024
3.5 Global Key Players of Multi-Target CAR-T Cell Therapy Head office and Area Served
3.6 Global Key Players of Multi-Target CAR-T Cell Therapy, Product and Application
3.7 Global Key Players of Multi-Target CAR-T Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multi-Target CAR-T Cell Therapy Breakdown Data by Type
4.1 Global Multi-Target CAR-T Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Multi-Target CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Multi-Target CAR-T Cell Therapy Breakdown Data by Application
5.1 Global Multi-Target CAR-T Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Multi-Target CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Multi-Target CAR-T Cell Therapy Market Size (2020-2031)
6.2 North America Multi-Target CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Multi-Target CAR-T Cell Therapy Market Size by Country (2020-2025)
6.4 North America Multi-Target CAR-T Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multi-Target CAR-T Cell Therapy Market Size (2020-2031)
7.2 Europe Multi-Target CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Multi-Target CAR-T Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Multi-Target CAR-T Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multi-Target CAR-T Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Multi-Target CAR-T Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Multi-Target CAR-T Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Multi-Target CAR-T Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multi-Target CAR-T Cell Therapy Market Size (2020-2031)
9.2 Latin America Multi-Target CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Multi-Target CAR-T Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Multi-Target CAR-T Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multi-Target CAR-T Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Multi-Target CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Multi-Target CAR-T Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Multi-Target CAR-T Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Persongen
11.1.1 Persongen Company Details
11.1.2 Persongen Business Overview
11.1.3 Persongen Multi-Target CAR-T Cell Therapy Introduction
11.1.4 Persongen Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025)
11.1.5 Persongen Recent Development
11.2 Juventas
11.2.1 Juventas Company Details
11.2.2 Juventas Business Overview
11.2.3 Juventas Multi-Target CAR-T Cell Therapy Introduction
11.2.4 Juventas Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025)
11.2.5 Juventas Recent Development
11.3 Gracell
11.3.1 Gracell Company Details
11.3.2 Gracell Business Overview
11.3.3 Gracell Multi-Target CAR-T Cell Therapy Introduction
11.3.4 Gracell Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025)
11.3.5 Gracell Recent Development
11.4 Precision-Biotech
11.4.1 Precision-Biotech Company Details
11.4.2 Precision-Biotech Business Overview
11.4.3 Precision-Biotech Multi-Target CAR-T Cell Therapy Introduction
11.4.4 Precision-Biotech Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025)
11.4.5 Precision-Biotech Recent Development
11.5 Carsgen
11.5.1 Carsgen Company Details
11.5.2 Carsgen Business Overview
11.5.3 Carsgen Multi-Target CAR-T Cell Therapy Introduction
11.5.4 Carsgen Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025)
11.5.5 Carsgen Recent Development
11.6 Novatim
11.6.1 Novatim Company Details
11.6.2 Novatim Business Overview
11.6.3 Novatim Multi-Target CAR-T Cell Therapy Introduction
11.6.4 Novatim Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025)
11.6.5 Novatim Recent Development
11.7 Bioheng
11.7.1 Bioheng Company Details
11.7.2 Bioheng Business Overview
11.7.3 Bioheng Multi-Target CAR-T Cell Therapy Introduction
11.7.4 Bioheng Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025)
11.7.5 Bioheng Recent Development
11.8 Iasobio
11.8.1 Iasobio Company Details
11.8.2 Iasobio Business Overview
11.8.3 Iasobio Multi-Target CAR-T Cell Therapy Introduction
11.8.4 Iasobio Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025)
11.8.5 Iasobio Recent Development
11.9 BMS
11.9.1 BMS Company Details
11.9.2 BMS Business Overview
11.9.3 BMS Multi-Target CAR-T Cell Therapy Introduction
11.9.4 BMS Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025)
11.9.5 BMS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Multi-Target CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Targeting CD19 and CD22
Table 3. Key Players of Targeting BCMA and CD19
Table 4. Key Players of Others
Table 5. Global Multi-Target CAR-T Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Multi-Target CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Multi-Target CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Multi-Target CAR-T Cell Therapy Market Share by Region (2020-2025)
Table 9. Global Multi-Target CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Multi-Target CAR-T Cell Therapy Market Share by Region (2026-2031)
Table 11. Multi-Target CAR-T Cell Therapy Market Trends
Table 12. Multi-Target CAR-T Cell Therapy Market Drivers
Table 13. Multi-Target CAR-T Cell Therapy Market Challenges
Table 14. Multi-Target CAR-T Cell Therapy Market Restraints
Table 15. Global Multi-Target CAR-T Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Multi-Target CAR-T Cell Therapy Market Share by Players (2020-2025)
Table 17. Global Top Multi-Target CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi-Target CAR-T Cell Therapy as of 2024)
Table 18. Ranking of Global Top Multi-Target CAR-T Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Multi-Target CAR-T Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Multi-Target CAR-T Cell Therapy, Headquarters and Area Served
Table 21. Global Key Players of Multi-Target CAR-T Cell Therapy, Product and Application
Table 22. Global Key Players of Multi-Target CAR-T Cell Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Multi-Target CAR-T Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Multi-Target CAR-T Cell Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Multi-Target CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Multi-Target CAR-T Cell Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Multi-Target CAR-T Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Multi-Target CAR-T Cell Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Multi-Target CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Multi-Target CAR-T Cell Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Multi-Target CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Multi-Target CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Multi-Target CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Multi-Target CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Multi-Target CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Multi-Target CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Multi-Target CAR-T Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Multi-Target CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Multi-Target CAR-T Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Multi-Target CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Multi-Target CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Multi-Target CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Multi-Target CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Multi-Target CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Multi-Target CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Persongen Company Details
Table 48. Persongen Business Overview
Table 49. Persongen Multi-Target CAR-T Cell Therapy Product
Table 50. Persongen Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 51. Persongen Recent Development
Table 52. Juventas Company Details
Table 53. Juventas Business Overview
Table 54. Juventas Multi-Target CAR-T Cell Therapy Product
Table 55. Juventas Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 56. Juventas Recent Development
Table 57. Gracell Company Details
Table 58. Gracell Business Overview
Table 59. Gracell Multi-Target CAR-T Cell Therapy Product
Table 60. Gracell Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 61. Gracell Recent Development
Table 62. Precision-Biotech Company Details
Table 63. Precision-Biotech Business Overview
Table 64. Precision-Biotech Multi-Target CAR-T Cell Therapy Product
Table 65. Precision-Biotech Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 66. Precision-Biotech Recent Development
Table 67. Carsgen Company Details
Table 68. Carsgen Business Overview
Table 69. Carsgen Multi-Target CAR-T Cell Therapy Product
Table 70. Carsgen Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 71. Carsgen Recent Development
Table 72. Novatim Company Details
Table 73. Novatim Business Overview
Table 74. Novatim Multi-Target CAR-T Cell Therapy Product
Table 75. Novatim Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 76. Novatim Recent Development
Table 77. Bioheng Company Details
Table 78. Bioheng Business Overview
Table 79. Bioheng Multi-Target CAR-T Cell Therapy Product
Table 80. Bioheng Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 81. Bioheng Recent Development
Table 82. Iasobio Company Details
Table 83. Iasobio Business Overview
Table 84. Iasobio Multi-Target CAR-T Cell Therapy Product
Table 85. Iasobio Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 86. Iasobio Recent Development
Table 87. BMS Company Details
Table 88. BMS Business Overview
Table 89. BMS Multi-Target CAR-T Cell Therapy Product
Table 90. BMS Revenue in Multi-Target CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 91. BMS Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Multi-Target CAR-T Cell Therapy Picture
Figure 2. Global Multi-Target CAR-T Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Multi-Target CAR-T Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Targeting CD19 and CD22 Features
Figure 5. Targeting BCMA and CD19 Features
Figure 6. Others Features
Figure 7. Global Multi-Target CAR-T Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Multi-Target CAR-T Cell Therapy Market Share by Application: 2024 VS 2031
Figure 9. Hematologic Malignancies Case Studies
Figure 10. Solid Tumors Case Studies
Figure 11. Others Case Studies
Figure 12. Multi-Target CAR-T Cell Therapy Report Years Considered
Figure 13. Global Multi-Target CAR-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Multi-Target CAR-T Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Multi-Target CAR-T Cell Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global Multi-Target CAR-T Cell Therapy Market Share by Players in 2024
Figure 17. Global Multi-Target CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Multi-Target CAR-T Cell Therapy Revenue in 2024
Figure 19. North America Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Multi-Target CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 21. United States Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Multi-Target CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 25. Germany Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Multi-Target CAR-T Cell Therapy Market Share by Region (2020-2031)
Figure 33. China Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Multi-Target CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 41. Mexico Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Multi-Target CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 45. Turkey Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Multi-Target CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Persongen Revenue Growth Rate in Multi-Target CAR-T Cell Therapy Business (2020-2025)
Figure 49. Juventas Revenue Growth Rate in Multi-Target CAR-T Cell Therapy Business (2020-2025)
Figure 50. Gracell Revenue Growth Rate in Multi-Target CAR-T Cell Therapy Business (2020-2025)
Figure 51. Precision-Biotech Revenue Growth Rate in Multi-Target CAR-T Cell Therapy Business (2020-2025)
Figure 52. Carsgen Revenue Growth Rate in Multi-Target CAR-T Cell Therapy Business (2020-2025)
Figure 53. Novatim Revenue Growth Rate in Multi-Target CAR-T Cell Therapy Business (2020-2025)
Figure 54. Bioheng Revenue Growth Rate in Multi-Target CAR-T Cell Therapy Business (2020-2025)
Figure 55. Iasobio Revenue Growth Rate in Multi-Target CAR-T Cell Therapy Business (2020-2025)
Figure 56. BMS Revenue Growth Rate in Multi-Target CAR-T Cell Therapy Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
